Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-27

Clinical Trial Update: ENA-001 for Post Operative Respiratory Depression (PORD) [Phase 2]

View source ↗

Summary

This entry notes that ENA-001 is in a Phase 2 trial for postoperative respiratory depression and that the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENA-001

Snippet

Sponsor: Enalare Therapeutics Inc. | Conditions: Respiratory Depression | Phase 2 | Status: NOT_YET_RECRUITING